Literature DB >> 8751410

Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy.

M Roach1, P Faillace-Akazawa, C Malfatti, J Holland, H Hricak.   

Abstract

PURPOSE: To compare the prostate volumes defined on magnetic resonance imaging (MRI), and noncontrast computerized tomographic (CT) scans used for three-dimensional (3D) treatment planning. METHODS AND MATERIALS: Ten patients were simulated for treatment using immobilization and a retrograde urethrogram. 3D images were used to compare prostate volumes defined by MRI (4-6 mm thick slices) and CT images (5 mm thick slices). Prostate volumes were calculated in cm(3) using the Scanditronix 3D planning system. MRI/CT images were merged using bony anatomy to define the regions of discrepancy in prostate volumes.
RESULTS: The mean prostate volume was 32% larger (range-5-63%) when defined by noncontrast CT compared to MRI. The areas of nonagreement tended to occur in four distinct regions of discrepancy: (a) the posterior portion of the prostate, (b) the posterior-inferior-apical portion of the prostate, (c) the apex due to disagreement between a urethrogram based definition and the location defined by MRI, (d) regions corresponding to the neurovascular bundle.
CONCLUSION: There is a tendency to overestimate the prostate volume by noncontrast CT compared to MRI. Awareness of this tendency should allow us to be to more accurately define the prostate during 3-D treatment planning.

Entities:  

Mesh:

Year:  1996        PMID: 8751410     DOI: 10.1016/0360-3016(96)00232-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  48 in total

Review 1.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

2.  Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds.

Authors:  Manabu Aoki; Atsunori Yorozu; Takushi Dokiya
Journal:  Jpn J Radiol       Date:  2009-12-25       Impact factor: 2.374

3.  Combining a deformable model and a probabilistic framework for an automatic 3D segmentation of prostate on MRI.

Authors:  Nasr Makni; P Puech; R Lopes; A S Dewalle; O Colot; N Betrouni
Journal:  Int J Comput Assist Radiol Surg       Date:  2008-12-03       Impact factor: 2.924

Review 4.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

5.  MR image-based synthetic CT for IMRT prostate treatment planning and CBCT image-guided localization.

Authors:  Shupeng Chen; Hong Quan; An Qin; Seonghwan Yee; Di Yan
Journal:  J Appl Clin Med Phys       Date:  2016-05-08       Impact factor: 2.102

6.  Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer.

Authors:  Bettina Hentschel; Wolfgang Oehler; Dirk Strauss; Andreas Ulrich; Ansgar Malich
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

7.  Cost-benefit analysis of 3D conformal radiation therapy.

Authors:  S H Levitt; F M Khan; P D Higgins; M B Nierengarten
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

8.  Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.

Authors:  Xiaofeng Yang; Peter Rossi; Tomi Ogunleye; David M Marcus; Ashesh B Jani; Hui Mao; Walter J Curran; Tian Liu
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

Review 9.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

10.  The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy.

Authors:  R Mazzola; S Fersino; A Fiorentino; F Ricchetti; N Giaj Levra; G Di Paola; G Sicignano; S Naccarato; R Ruggieri; F Alongi
Journal:  Clin Transl Oncol       Date:  2015-08-07       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.